Association between hypertension and immunosuppression in SARS-CoV-2 infection

• Autores: Chambergo Campos, Isidro Percy, Chambergo Michilot, Diego
• Formato: otro
• Fecha de Publicación: 2021
• Institución: Universidad Tecnológica del Perú
• Repositorio: UTP-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.utp.edu.pe:20.500.12867/4572
• Enlace del recurso: https://hdl.handle.net/20.500.12867/4572; https://doi.org/10.29333/ejgm/10867
• Nivel de acceso: acceso abierto
• Materia: Ciencias de la salud; COVID-19; Salud pública; Health sciences; Public health; https://purl.org/pe-repo/ocde/ford#3.00.00

Coronavirus disease 2019 (COVID-19) has caused more than 32 million cases and almost a million deaths. Recent reviews have evidenced the role of hypertension in prognosis, nevertheless, its association with immunosuppression in COVID-19 context has not been studied. It was performed a cross-sectional analysis of a large Mexican population with the infection (n= 681 890). Prevalence of immunosuppression and hypertension was 1.10% and 19.50%, respectively. The adjusted model evidenced that hypertension was significantly associated with immunosuppression (odds ratio=1.18, 95% CI=1.11-1.25). Furtherresearch in pathways thatjustify the association between hypertension and immunosuppression in COVID-19 patients is recommended.